Oral Selexipag Safe, Effective in Children With Pulmonary Arterial Hypertension - Pulmonology Advisor
Oral Selexipag Safe, Effective in Children With Pulmonary Arterial Hypertension - Pulmonology Advisor Oral Selexipag Safe, Effective in Children With Pulmonary Arterial Hypertension - Pulmonology Advisor Posted: 27 May 2020 08:30 AM PDT With close monitoring, the use of oral add-on treatment with selexipag in children with pulmonary arterial hypertension (PAH) was safe and well tolerated, according to the results of a prospective, observational study published in The Journal of Heart and Lung Transplantation . Researchers from the European Pediatric Pulmonary Vascular Disease Network (EPPVDN) conducted in consecutive children with PAH who were treated with oral selexipag at 3 tertiary pulmonary hypertension (PH) centers. The researchers sought to evaluate the efficacy and safety of the oral prostacyclin receptor agonist selexipag, which has been approved for use in adult patients with PAH. The current analysis is the largest, explorator...